Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients
暂无分享，去创建一个
V. Kulasingam | Deepali Kumar | A. Humar | V. Ferreira | J. Delisle | B. Majchrzak-Kita | M. Kimura | J. Mattsson | A. Mah | M. Ierullo | S. Hosseini-Moghaddam | Ivan Pašić | Sagar Kothari | I. Pašić | S. Kothari